Immediate Impact
52 standout
Citing Papers
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Ming‐Chih Hou being referenced
A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ming‐Chih Hou | 962 | 773 | 598 | 102 | 1.4k | |
| Ming-Chih Hou | 962 | 931 | 478 | 101 | 1.6k | |
| Paola Ceppa | 569 | 747 | 537 | 58 | 1.7k | |
| Wei‐Lun Tsai | 590 | 584 | 542 | 77 | 1.3k | |
| S A Jenkins | 537 | 561 | 429 | 65 | 1.2k | |
| Gin‐Ho Lo | 1276 | 1042 | 1055 | 60 | 1.9k | |
| Yuan‐Hung Kuo | 682 | 612 | 388 | 79 | 1.2k | |
| William Kemp | 898 | 1167 | 461 | 117 | 1.9k | |
| Young Woon Chang | 694 | 724 | 488 | 134 | 1.6k | |
| Bich Nguyen | 644 | 668 | 659 | 91 | 1.9k | |
| Anastasios A. Mihas | 969 | 1071 | 827 | 59 | 2.0k |
All Works
Loading papers...